TheScreener - Mouwasat Medical Services Co. (4002) MOUWASAT MEDICAL SVS. receives a double requalification that leads to a downgrade to Neutral

Report

TheScreener

EUR 13.23 For Business Accounts Only

MOUWASAT MEDICAL SVS. receives a double requalification that leads to a downgrade to Neutral

MOUWASAT MEDICAL SVS. (SA), a company active in the Health Care Providers industry, sees its general evaluation downgraded to Neutral on account of a double requalification. The independent financial analyst theScreener just removed a fundamental star(s) for a 2 over 4-star rating. As such, market behaviour has also deteriorated and is evaluated as moderately risky. theScreener believes that the loss of a star(s) and the increased risk justifies the general evaluation downgrade, which passes to Neutral. As of the analysis date April 1, 2022, the closing price was SAR 212.60 and its expected value was estimated at SAR 207.03.

02/04/2022 1 EN

Underlying

Mouwasat Medical Services Co.

Mouwasat Medical Services Company SJSC Formerly known as Mouwasat Medical Services Company. Mouwasat Medical Services Co SJSC is a Saudi Arabia-based company engaged in the ownership, management, operation and maintenance of hospitals, medical centers, drug stores, pharmacies and wholesale of medical equipment and drugs. The Company operates five hospitals, including Mouwasat Hospital in Dammam, Mouwasat Hospital in Jubail, Mouwasat Hospital in Madinah and Mouwasat Hospital in Qatif. In addition, the Company also operates specialized centers, which include Skin Care Centers, Mouwasat Care Fertility and Badana Clinic, as well as dispensaries and pharmacies. The Company's subsidiaries include Eastern Medical Services Company Limited, which is engaged in construction and operation of hospitals, dispensaries and special clinics, and Specialized Medical Clinic Company Limited, which is engaged in construction, management and operation of clinic (plastic surgery). The Company also has 50% ownership in Advance Medical Project Company (AMPC).

See profile

SA12C051UH11 Saudi Stock Exchange Saudi Arabia

Provider

TheScreener

Empowering Investors

theScreener is the market leader for independent valuations of financial securities, equities, sectors and markets, and new funds. theScreener's ratings, analyses are used by leading banks, asset managers and financial portals. Approximately 10,000 workstations benefit from theScreener's services, with over millions of customer accounts actively analysed.

Worldwide coverage: theScreener analyses cover around 6'500 Stocks, i.e 95% of the world Market Capitalization. theScreener state of art: We provide
theScreener state of art: We provide easy to use and complete analyses over Stocks, including Fundamentals / Technical / Risk/ Peer / Alternatives analyses.
For Research Pool community, we provide twice a week around 500 new equity analyses. We produce analyses about equities which have been upgraded or downgraded.

See profile

Other Reports on these Companies

Tellimer

Saudi Healthcare Sector update: NHIC to drive growth

We maintain our long-term positive outlook on the Saudi Healthcare sector. The introduction of NHIC is a key catalyst for the sector which is expected to 1) increase the insurance penetration by 3x and 2) improve the receivables cycle. We expect the sector's bed capacity to record a CAGR of 10% during 2022-25f, while revenue and net income are forecasted to grow at a CAGR of 13.7% and 21.7%, respectively. We maintain our neutral rating across our coverage, as we believe the current valuations...

PREMIUM

April 5, 2023 April 5, 2023 1 EN

Tellimer

Mouwasat: Q3 22 Results Analysis | New hospital costs drive earnings miss

Mouwasat reported a weak set of results with a net income of SAR122mn, down 14.3% yoy (-13.6% qoq) in Q3 22. This is lower than the SNB Capital and consensus estimates of SAR142mn and SAR143mn, respectively. The variance in bottom-line was due to initial costs related to ramp up of expansion of Mouwasat Hospital in Dammam and the New Mouwasat Hospital in Madinah. Additionally, increase in financial costs also pressurized the earnings. Revenues for Mouwasat increased 3.4% yoy (-1.6% qoq) to SA...

PREMIUM

November 10, 2022 November 10, 2022 1 EN

Tellimer

Mouwasat: Expansion activities lead to earnings miss

Mouwasat reported a broadly in-line set of Q2 22 results. Although the net income remained flat yoy (-5.8% qoq) at of SAR141mn in Q2 22, it was in-line with the SNB Capital and consensus estimates of SAR148mn and SAR145mn, respectively. The flat bottom-line was a function of 5.9% yoy (-1.6% qoq) revenue growth to SAR558mn, which was offset by a contraction of gross margins. * Revenue increased by 5.9% yoy (-1.6% qoq) to SAR558mn and was in-line with our estimate. The revenues increased due t...

PREMIUM

August 16, 2022 August 16, 2022 1 EN

AC ENERGY CORP increases its risk exposure and slightly lowers to Neutral

AC ENERGY CORP (PH), a company active in the Alternative Electricity industry, now shows a lower overall rating. The independent financial analyst theScreener confirms the fundamental rating of 4 out of 4 stars. However, the market behaviour deterioration triggered a risk requalification, which can be thus described as moderately risky. theScreener believes that increased risk justifies the general evaluation downgrade to Neutral. As of the analysis date April 8, 2022, the closing price was PHP 8.54 and its expected value was estimated at PHP 8.53.

Free Trial

April 9, 2022 April 9, 2022 1 EN

With a more favourable environment, VUKILE PROPERTY improves to Positive

VUKILE PROPERTY (ZA), a company active in the Real Estate Holding & Development industry, is favoured by a more supportive environment. The independent financial analyst theScreener has confirmed the fundamental rating of the title, which shows 4 out of 4 stars, as well as its unchanged, defensive market behaviour. The title leverages a more favourable environment and raises its general evaluation to Positive. As of the analysis date April 5, 2022, the closing price was ZAR 13.72 and its potential was estimated at ZAR 15.16.

Free Trial

April 6, 2022 April 6, 2022 1 EN

An unfavourable environment weighs on ROYAL BAFOKENG PLATINUM, which sees a downgrade to Slightly Negative

The independent financial analyst theScreener just requalified the general evaluation of ROYAL BAFOKENG PLATINUM (ZA), active in the Platinum & Precious Metals industry. As regards its fundamental valuation, the title still shows 0 out of 4 stars and its market behaviour is seen as moderately risky. theScreener believes that the unfavourable environment weighs on the sector and penalises the company, which sees a downgrade to its general evaluation to Slightly Negative. As of the analysis date April 5, 2022, the closing price was ZAR 159.78 and its target price was estimated at ZAR 127.50.

Free Trial

April 6, 2022 April 6, 2022 1 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

MOUWASAT MEDICAL SVS. receives a double requalification that leads to a downgrade to Neutral

Empowering Investors

Saudi Healthcare Sector update: NHIC to drive growth

Mouwasat: Q3 22 Results Analysis | New hospital costs drive earnings miss

Mouwasat: Expansion activities lead to earnings miss

AC ENERGY CORP increases its risk exposure and slightly lowers to Neutral

With a more favourable environment, VUKILE PROPERTY improves to Positive

An unfavourable environment weighs on ROYAL BAFOKENG PLATINUM, which sees a downgrade to Slightly Negative

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe